INTRODUCTION
Sickle cell anaemia (SCA) is one of the commonest inherited disorders in man. It is prevalent in Central Africa, Eastern Countries, Mediterranean region and parts of India.
In India SCA is highly prevalent in certain communitie~ in Central India like Mahars, Teli's and Kunbi's in areas around Nagpur (1). Mukherjee MB (2) found that the prevalence of sickle cell trait among Mahars in Nagpur was 22.2%.
Sickle cell anaemia results from a point mutation in the genetic code such that a single amino acid (glutamic acid) is replaced by another (valine) in the globin chain of haemoglobin (Hb). This substitution transforms normal adult haemoglobin (HbA) into sickle haemoglobin (HbS).
If an individual is homozygous for the sickle cell mutation (HbSS) almost all the haemoglobin is sickle haemoglobin.
In the heterozygous individual
Author for correspondence :
Dr. Jyoti Titus Lecturer, Department of Biochemistry, Indira Gandhi Medical College, Nagpur 440 018
Indian Journal of Clinical Biochemistry, 2004
(HbAS) upto 40% of the haemoglobin is sickle haemoglobin. Under conditions of low oxygen tension HbS molecules undergo aggregation and polymerize and the red cells aquire a 'sickle' or 'holly leaf' shape. Sickling of red cells leads to two major consequences, a chronic haemolytic anaemia and occlusion of small blood vessels resulting in ischemic tissue damage.
Sickle cell anaemia is a condition in which there is observed oxidative stress in the body. There are reports available which indicate that sickle cell erythrocytes produce twice as much superoxide, hydrogen peroxide and hydroxyl radical as compared to normal healthy controls (3). There are also reports which indicate significantly enhanced lipid peroxidation in sickle cell anaemia as compared to controls. But there are contradictory reports as far as the status of the anti -oxidants is concerned in these patients specially that of superoxide dismutase and ascorbic acid (vitamin C).
The prevalence of sickle cell anaemia is alarmingly high in Vidarbha region. Very few studies have been carried on the role of free radicals and status of anti -oxidants in SCA patients in this region. Moreover no study has been carded out to compare the pro-oxidant and anti-oxidant status in homozygous and heterozygous SCA patients. It was with this view in mind that it was thought pertinent to assess and evaluate the pro-oxidant and antioxidant status in homozygous as well as heterozygous patients and to possibly identify whether these parameters could be in any way associated with the patho-physiology of the disease.
MATERIAL AND METHODS
The present study was carried out on 107 cases of sickle cell anaemia attending the Regional Haemoglobinopathy Detection Centre (RHDC) at Indira Gandhi Medical College, Nagpur. A total number of 54 healthy, age and sex matched controls were also chosen for the study. Homozygous cases belonged to the age group 11-30 years while heterozygous cases and controls were between the age group of 11-40 years. All * were free from acute illness like URTI / fever etc. None had history of concomitant illness like ** Rheumatic Heart Disease / Diabetes mellitus./ Hypertension or others. Patients of SCA in acute # crises were excluded from the study. Homozygous patients with history of blood transfusion within past 3 months were excluded from the study. All the cases and controls chosen for the study gave their written consent for participating in the study after being explained the nature of the study.
Haemolysed samples were excluded from the study. The blood samples were collected in an EDTA vial for estimation of superoxide dismutase [based on the reaction between superoxide radicals and 2-4-iodophenyl-3-4-nitrophenol-5-phenyltetrazolium chloride (INT), (4) 
RESULTS AND DISCUSSION
As seen in Table I , significantly higher levels of malondialdehyde were observed in both homozygous as well as heterozygous sickle cell anaemia patients as compared to controls. Earlier reports (8) , (9), (10) patients can be attributable to the increased autoxidation and iron decompartmentalisation seen in these patients (11) . The accelerated HbS autooxidation results in accelerated superoxide production resulting in the formation of pathological amounts of hydrogen peroxide due to superoxide dismutation. The hydrogen peroxide, which is formed, produces hydroxyl radicals (.OH) in the presence of iron.
The accelerated oxygen radical production can have serious adverse effects on cell membrane protein and lipid resulting in thiol oxidation and lipid peroxidation. Lipid peroxidation can affect the activities of certain enzymes, like the Na § -K* ATPase (12) and Ca" ATPase (13) , in the sickle cell. The deformability of sickle RBC's is diminished by exposure to malondialdehyde causing increased rigidity, dehydration and decreased deformability of RBC's (14) . Table I , the levels of the enzyme superoxide dismutase (SOD) were significantly increased in both homozygous as well as heterozygous patients of sickle cell anaemia. The increased levels of SOD, as found in this study, could be able to dismutate the increased flux of superoxide ions, exposing the sickle erythrocytes to high levels of hydrogen peroxide. The weakly membrane bound GSH -Px enzyme, could prevent lipid peroxidation of the sickle cell membrane. However, reduced catalase activity, reported in eadier studies, will not be able to protect the cytosolic components from the toxicity of hydrogen peroxide.
The situation is further compounded by the low levels of certain anti-oxidant vitamins seen in these patients. Table I depicts that the levels of vitamin C were significantly lower in homozygous as well as heterozygous SCA patients. This findings are in agreement with the findings of Jain S (19) who found that homozygous SCA patients had significantly lower levels of vitamin C. However Adelekan eta/. (20) did not find any significant difference in the levels of vitamin C between heterozygous SCA patients and controls. The role of vitamin C as an anti-oxidant is well known. Chou PT, Khan AU (21) proposed that while ascorbic acid may act synergistically with vitamin E, the anti-oxidant effect may be due to quenching of singlet oxygen in the aqueous medium.
Other authors have reported lower levels of plasma and RBC membrane vitamin E in SCA patients as compared to controls. Therapy with vitamins C and E in patients of sickle cell anaemia may be considered as sickle cell patients tend to be deficient in them. There is paucity of literature as far as supplementation of vitamin C in SCA patients is concerned. Small trials of vitamin C supplementation have been carded out (22) .
Albumin exerts its anti-oxidant effect in the body by binding copper ions and heme tightly and iron ions weakly. It thus plays a role in preventing copper and iron from participating in lipid peroxidation. However as shown in table I, there was no significant difference in the levels of albumin in the homozygous patients or heterozygous SCA subjects as compared to controls, The results of this study indicate that there is no significant effect of age or sex on lipid peroxidation in both SCA groups (Bar diagrams I and II). The haemoglobin levels in both the SCA groups were significantly lower as compared to controls. This indicates that the oxidative damage in sickle cell trait may be strong enough to result in significantly lower haemoglobin levels in both male and female sickle cell trait cases. A modest decrease in the Bar Diagram II. MDA levels in male and female cases of sickle cell anaemia hemoglobin level in sickle cell trait has been documented (23) . Reports suggest that sickle cell trait may contribute to a patient's illness (24) .Thus, the sickle cell trait may not be a =benign" form of sickle cell anaemia as considered earlier.
In conclusion, it is clearly evident that both homozygous as well as heterozygous patients are exposed to enhanced oxidative stress as compared to controls. It is also evident that the anti-oxidant system is imbalanced in these patients and is probably unable to effectively counteract the augmented oxidative stress. It now remains to be seen whether oral supplementation of anti-oxidant vitamins could be of help to these patients.
